{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:17:30Z","timestamp":1762899450660,"version":"3.40.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:00Z","timestamp":1496188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:00Z","timestamp":1496188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12098-017-2383-4","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T01:58:15Z","timestamp":1496195895000},"page":"117-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Newer Vaccines against Mosquito-borne Diseases"],"prefix":"10.1007","volume":"85","author":[{"given":"Anju","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,31]]},"reference":[{"key":"2383_CR1","unstructured":"Caraballo H, King K. Emergency department management of mosquito-borne illness: malaria, dengue, and West Nile virus. Emerg Med Pract. 2014;16:1\u201323. quiz 23\u20134."},{"key":"2383_CR2","unstructured":"World Health Organization Japanese encephalitis. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs386\/en\/. Accessed on 26th Jan 2017."},{"key":"2383_CR3","unstructured":"Centers for Disease Control and Prevention (CDC) Japanese Encephalitis - Chapter 3 - 2016 Yellow Book Travelers\u2019 Health. Available at: https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2016\/infectious-diseases-related-to-travel\/japanese-encephalitis. Accessed on 21st Jan 2016."},{"key":"2383_CR4","unstructured":"Centers for Disease Control and Prevention (CDC). Use of Japanese encephalitis vaccine in children: recommendations of the Advisory Committee on Immunization Practices, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:898\u2013900."},{"key":"2383_CR5","unstructured":"Fischer M, Lindsey N, Staples JE, Hills S; Centers for Disease Control and Prevention (CDC). Japanese encephalitis vaccines: recommendations of the Advisory Committee on immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59:1\u201327."},{"key":"2383_CR6","unstructured":"Advisory Committee on Vaccines and Immunization Practices of Indian Academy of Pediatrics (ACVIP of IAP). Available at: http:\/\/acvip.org\/professional\/columns\/je-vaccines. Accessed on 23rd Jan 2017."},{"key":"2383_CR7","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1080\/21645515.2015.1011996","volume":"11","author":"SY Wang","year":"2015","unstructured":"Wang SY, Cheng XH, Li JX, Li XY, Zhu FC, Liu P. Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: a systematic review and meta-analysis. Hum Vaccin Immunother. 2015;11:1418\u201325.","journal-title":"Hum Vaccin Immunother"},{"key":"2383_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3346\/jkms.2015.30.5.612","volume":"30","author":"HJ Kwon","year":"2015","unstructured":"Kwon HJ, Lee SY, Kim KH, et al. The immunogenicity and safety of the live-attenuated SA 14-14-2 Japanese encephalitis vaccine given with a two-dose primary schedule in children. J Korean Med Sci. 2015;30:612\u20136.","journal-title":"J Korean Med Sci"},{"key":"2383_CR9","doi-asserted-by":"crossref","unstructured":"Sanchayan K, Fernandopulle R, Amarasinghe A, Thiyahiny SN, Sri Ranganathan S. Safety of live attenuated Japanese encephalitis vaccine given at the age of 9\u00a0mo in National Immunisation Programme of Sri Lanka. Ceylon Med J. 2016;61:99\u2013105.","DOI":"10.4038\/cmj.v61i3.8344"},{"key":"2383_CR10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1086\/378356","volume":"188","author":"TP Monath","year":"2003","unstructured":"Monath TP, Guirakhoo F, Nichols R, et al. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis. 2003;188:1213\u201330.","journal-title":"J Infect Dis"},{"key":"2383_CR11","unstructured":"Health AGD of. 4.8 Japanese encephalitis. Australian Government Department of Health. Available at: http:\/\/www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/Handbook10-home~handbook10part4~handbook10-4-8. Accessed on 22nd Feb 2017."},{"key":"2383_CR12","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/INF.0000000000001395","volume":"36","author":"S Sricharoenchai","year":"2017","unstructured":"Sricharoenchai S, Lapphra K, Chuenkitmongkol S, et al. Immunogenicity of a live attenuated chimeric Japanese encephalitis vaccine as a booster dose after primary vaccination with live attenuated SA14-14-2 vaccine: a phase IV study in Thai children. Pediatr Infect Dis J. 2017;36:e45\u20137.","journal-title":"Pediatr Infect Dis J"},{"key":"2383_CR13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.4161\/hv.6.11.12854","volume":"6","author":"PE Nasveld","year":"2010","unstructured":"Nasveld PE, Marjason J, Bennett S, et al. Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity. Hum Vaccin. 2010;6:906\u201314.","journal-title":"Hum Vaccin"},{"key":"2383_CR14","unstructured":"World Health Organization. Yellow fever. Available at: http:\/\/www.who.int\/ith\/vaccines\/yf\/en\/. Accessed on 24th Jan 2017."},{"key":"2383_CR15","unstructured":"Yf-Vax (Yellow Fever Vaccine): Side effects, interactions, warning, dosage & uses. Available at: http:\/\/www.rxlist.com\/yellow-fever-vaccine-drug.htm. Accessed on 22nd Feb 2017."},{"key":"2383_CR16","unstructured":"Centers for Disease Control and Prevention (CDC) Vaccine Information Statement. Yellow Fever. Available at: https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/yf.html. Accessed on 28th Jan 2017."},{"key":"2383_CR17","unstructured":"World Health Organization Malaria. Available at: http:\/\/www.who.int\/gho\/malaria\/en\/. Accessed on 16th Jan 2017."},{"key":"2383_CR18","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/milmed\/134.9.1176","volume":"134","author":"R Nussenzweig","year":"1969","unstructured":"Nussenzweig R, Vanderberg J, Most H. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. IV. Dose response, specificity and humoral immunity. Mil Med. 1969;134:1176\u201382.","journal-title":"Mil Med"},{"key":"2383_CR19","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1098\/rstb.2011.0091","volume":"366","author":"AVS Hill","year":"2011","unstructured":"Hill AVS. Vaccines against malaria. Philos Trans R Soc B Biol Sci. 2011;366:2806\u201314.","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"2383_CR20","unstructured":"Joint Technical Expert Group & World Health Organization. Background Paper on the RTS,S\/AS01 Malaria Vaccine, 2015. Available at: http:\/\/www.who.int\/immunization\/sage\/ meetings\/2015\/october\/1_Final_malaria_vaccine_background_paper_v2015_09_30.pdf. Accessed on 22nd Jan 2017."},{"key":"2383_CR21","unstructured":"World Health Organization. Questions and answers on RTS,S\/ASO1 malaria vaccine. Available at: http:\/\/www.who.int\/immunization\/research\/development\/malaria_vaccine_qa\/en\/. Accessed on 18th Jan 2017."},{"key":"2383_CR22","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","volume":"367","author":"The RTS SCTP","year":"2012","unstructured":"The RTS SCTP. A phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants. N Engl J Med. 2012;367:2284\u201395.","journal-title":"N Engl J Med"},{"key":"2383_CR23","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1473-3099(16)00026-8","volume":"16","author":"JD Stanaway","year":"2016","unstructured":"Stanaway JD, Shepard DS, Undurraga EA, et al. The global burden of dengue: an analysis from the global burden of disease study 2013. Lancet Infect Dis. 2016;16:712\u201323.","journal-title":"Lancet Infect Dis"},{"key":"2383_CR24","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1086\/518148","volume":"45","author":"R Edelman","year":"2007","unstructured":"Edelman R. Dengue vaccines approach the finish line. Clin Infect Dis. 2007;45:S56\u201360.","journal-title":"Clin Infect Dis"},{"key":"2383_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-med-091014-090848","volume":"67","author":"B Guy","year":"2016","unstructured":"Guy B, Lang J, Saville M, Jackson N. Vaccination against dengue: challenges and current developments. Annu Rev Med. 2016;67:387\u2013404.","journal-title":"Annu Rev Med"},{"key":"2383_CR26","unstructured":"World Health Organization. Dengue. Available at: http:\/\/www.who.int\/immunization\/sage\/meetings\/2016\/april\/2_Smith_Clinical_Trial_Results_SAGE.pdf. Accessed on 24th Feb 2017."},{"key":"2383_CR27","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.vaccine.2016.10.070","volume":"35","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Dengue vaccine: WHO position paper, July 2016 - recommendations. Vaccine. 2017;35:1200\u20131.","journal-title":"Vaccine"},{"key":"2383_CR28","doi-asserted-by":"publisher","unstructured":"Rodriguez Melo FI, Morales JJR, De Los Santos AHM, Rivas E, Vigne C, Noriega F. Immunogenicity and safety of a booster injection of DTap-IPV\/\/Hib (Pentaxim\u00ae) administered concomitantly with tetravalent dengue vaccine in healthy toddlers aged 15 to 18\u00a0mo in Mexico: a randomized trial. Pediatr Infect Dis J. 2017. doi:10.1097\/INF.0000000000001542.","DOI":"10.1097\/INF.0000000000001542"},{"key":"2383_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2217\/cer-2016-0045","volume":"6","author":"IP God\u00f3i","year":"2017","unstructured":"God\u00f3i IP, Pires Lemos LL, de Ara\u00fajo VE, Bonoto BC, Godman B, Guerra J\u00fanior AA. CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety. J Comp Eff Res. 2017;6:165\u201380.","journal-title":"J Comp Eff Res"},{"key":"2383_CR30","unstructured":"World Health Organization Strategic Advisory Group of Experts (SAGE) on Immunization. Background paper on dengue vaccines prepared by the SAGE working group on Dengue vaccines. Available at: http:\/\/www.who.int\/immunization\/sage\/meetings\/2016\/april\/presentations_background_docs\/en\/. Accessed on 3rd Mar 2017."},{"key":"2383_CR31","doi-asserted-by":"crossref","unstructured":"Brandler S, Tangy F. Vaccines in development against West Nile virus. Viruses. 2013;5:2384\u2013409.","DOI":"10.3390\/v5102384"},{"key":"2383_CR32","doi-asserted-by":"publisher","first-page":"10324","DOI":"10.1128\/JVI.00480-13","volume":"87","author":"N Petrovsky","year":"2013","unstructured":"Petrovsky N, Larena M, Siddharthan V, et al. An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody. J Virol. 2013;87:10324\u201333.","journal-title":"J Virol"},{"key":"2383_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/infdis\/jiw501","volume":"215","author":"KK Pierce","year":"2017","unstructured":"Pierce KK, Whitehead SS, Kirkpatrick BD, et al. A live attenuated chimeric West Nile virus vaccine, rWN\/DEN4\u039430, is well tolerated and immunogenic in Flavivirus-naive older adult volunteers. J Infect Dis. 2017;215:52\u20135.","journal-title":"J Infect Dis."},{"key":"2383_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.vaccine.2016.11.080","volume":"35","author":"EA Poore","year":"2017","unstructured":"Poore EA, Slifka DK, Rau\u00e9 H-P, et al. Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine. Vaccine. 2017;35:283\u201392.","journal-title":"Vaccine"},{"key":"2383_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1055\/s-0036-1592070","volume":"34","author":"AP Durbin","year":"2016","unstructured":"Durbin AP. Vaccine development for Zika virus-timelines and strategies. Semin Reprod Med. 2016;34:299\u2013304.","journal-title":"Semin Reprod Med"},{"key":"2383_CR36","unstructured":"Testing Begins On An Experimental Zika Vaccine With Inactivated Virus. Available at: http:\/\/www.npr.org\/sections\/health-shots\/2016\/11\/07\/501015866\/testing-begins-on-an-experimental-zika-vaccine-with-inactivated-virus. Accessed on 23rd Jan 2017."},{"key":"2383_CR37","unstructured":"World Health Organization. Chikungunya. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs327\/en\/. Accessed on 28th Jan 2017."},{"key":"2383_CR38","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1586\/erv.12.84","volume":"11","author":"SC Weaver","year":"2012","unstructured":"Weaver SC, Osorio JE, Livengood JA, Chen R, Stinchcomb DT. Chikungunya virus and prospects for a vaccine. Expert Rev Vaccines. 2012;11:1087\u2013101.","journal-title":"Expert Rev Vaccines"},{"key":"2383_CR39","doi-asserted-by":"crossref","unstructured":"Erasmus JH, Auguste AJ, Kaelber JT, et al. A chikungunya fever vaccine utilizing an insect-specific virus platform. Nat Med advance online publication. Available at: http:\/\/www.nature.com\/nm\/journal\/vaop\/ncurrent\/full\/nm.4253.html. Accessed on 23rd Jan 2017.","DOI":"10.1038\/nm.4253"},{"key":"2383_CR40","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","volume":"15","author":"K Ramsauer","year":"2015","unstructured":"Ramsauer K, Schwameis M, Firbas C, et al. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet Infect Dis. 2015;15:519\u201327.","journal-title":"Lancet Infect Dis"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-017-2383-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2383-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2383-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:50:47Z","timestamp":1744174247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-017-2383-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,31]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2383"],"URL":"https:\/\/doi.org\/10.1007\/s12098-017-2383-4","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"type":"print","value":"0019-5456"},{"type":"electronic","value":"0973-7693"}],"subject":[],"published":{"date-parts":[[2017,5,31]]},"assertion":[{"value":"21 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of Funding"}}]}}